NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Guideline Centre (UK). Chronic Heart Failure in Adults: Diagnosis and Management. London: National Institute for Health and Care Excellence (NICE); 2018 Sep. (NICE Guideline, No. 106.)
| Acronym or abbreviation | Description |
|---|---|
| 6MWT | 6 Minute Walk Test |
| ACA | |
| ACC/AHA | American College of Cardiology/American Heart Assocation |
| AE | Adverse events |
| ACE | Angiotensin-converting enzyme |
| ACE-I | Angiotensin converting enzyme inhibitors |
| ACS | Acute Coronary Syndrome |
| ADHF/AHF | Acute decompensated heart failure/Acute heart failure |
| ADMIRE-HF | AdreView Myocardial Imaging for Risk Evaluation in Heart Failure |
| AF | Atrial fibrillation |
| AKI | Acute kidney injury |
| AMCKD | Anaemia management in people with chronic kidney disease |
| AUC | Area under the curve |
| ARA | Action research arm |
| ARB | Angiotensin II receptor blockers |
| ARD | Assessment Reference Date |
| AROC | Australasian Rehabilitation Outcomes Centre |
| BB | Beta-blocker |
| BBL | |
| BEST | Beta-Blocker Evaluation of Survival Trial |
| BHF | British Heart Foundation |
| BMI | Body Mass Index |
| BMT | Best medical therapy |
| BNF | British National Formulary |
| BNP | B-type natriuretic peptide |
| BP | Blood pressure |
| CAD | Coronary artery disease |
| CAS | Complex Adaptive System |
| CABG | Coronary artery bypass grafting |
| CC | Comparative cost |
| CCA | Cost-consequence analysis |
| CCS | |
| CDR | Clinical Decision Rule |
| CE | Cost effective |
| CEA | Cost effectiveness analysis |
| CERQual | Confidence in the Evidence from Reviews of Qualitative Research’ |
| CG | Control group |
| CHF | Chronic heart failure |
| CI | Confidence intervals |
| CINAHL | Cumulative Index of Nursing and Allied Health Literature |
| CKD | Chronic kidney disease |
| CM | Cardiomyopathy |
| cMRI | Cardiac Magnetic Resonance Imaging |
| COPD | Chronic obstructive pulmonary disease |
| CPET | Cardiopulmonary exercise testing |
| CR | Cardiac rehabilitation |
| CRT | Cardiac resynchronisation therapy |
| CUA | Cost-utility analysis |
| CV mortality | Cardiovascular mortality |
| CXR | Chest X-ray |
| DM | Diabetes mellitus |
| DRG | Diagnosis-related group |
| EBM | Evidence based medicine |
| ECHO | Extension for Community Healthcare Outcomes |
| EDTA | Ethylene diamine tetraacetic acid |
| EF | Ejection fraction |
| EGFR | Estimated glomerular filtration rate |
| EHO | |
| EIMA | |
| EME | Efficacy and Mechanism Evaluation |
| ELISA | Enzyme-linked immunosorbent assay |
| ESC | European Society of Cardiology |
| EQ-5D | Euroqual (measurement of health outcomes) |
| GC | Guideline Committee |
| GFS | |
| FCM | Ferric carboxymaltose |
| FDA | Food and Drug Administration |
| FG | Focus group |
| FN | False negative |
| FP | False positive |
| FVC | Forced vital capacity |
| GFR | Glomerular filtration rate |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HBT | Home-Based Tele-management |
| HCAHPS | Hospital Consumer Assessment of Healthcare Providers and Systems |
| HCP | Healthcare professional |
| HDS | Heart disease and stroke |
| HMRS | HeartMate II Risk Score |
| HEED | Health Economic Evaluations Database |
| HF | Heart failure |
| HFPEF | Heart failure with preserved ejection fraction |
| HFREF | Heart failure with reduced ejection fraction |
| HLR | Heart-to-lung ratio |
| HETG | Home-based exercise training group |
| HFMS | Heart Failure Monitoring System |
| HH | Human to human interface |
| HTA | Health Technology Appraisal |
| HTN | Hypertension |
| HR | Hazard ratio |
| HRQoL | Heath-related quality of life |
| ICD | Implantable Cardioverter Defibrillators |
| ICU | Intensive care unit |
| ICER | Incremental cost-effectiveness ratio |
| IG | Interventions group |
| IHD | Ischemic heart disease |
| IIM | Intrathoracic impedance measurement |
| IN-CHF | Italian Heart Failure Registry |
| INR | International normalized ratio |
| IPD | Individual patient data |
| IQR | Interquartile range |
| ISWT | Incremental shuttle walk test |
| ITT | Intention-to-treat analysis |
| IV | Intravenous |
| JVP | Jugular venous pressure |
| LTC | Long term care |
| LTOT | Long term oxygen therapy |
| LV | Left ventricle |
| LVAD | Left Ventricular Assist Device |
| LVER | Left Ventricular Ejection Fraction |
| LVSD | Left ventricular systolic dysfunction |
| LY | Life year |
| LYG | Life years gained |
| MAGGIC | Meta-analysis Global Group in Chronic Heart Failure |
| MD | Medical devices |
| MDRD | Modification of Diet in Renal Disease Study |
| MDT | Multidisciplinary team |
| MHRA | Medicines and Healthcare products Regulatory Agency |
| MI | Myocardial infarction |
| MIBG | Meta-iodobenzylguanidine |
| MICE | Male, Infarction, Crepitations, Edema |
| MID | Minimal important differences |
| Minnesota LWHFQ | Minnesota Living With Heart Failure Questionnaire |
| MLWHF | Minnesota Living with Heart Failure |
| MCS | Mental component summary |
| MRA | Mineralocorticoid receptor antagonists |
| MRC | London Institute of Medical Sciences |
| NSAIDS | Non-steroidal anti-inflammatory drugs |
| NGC | National Guideline Centre |
| NHLBI | National Heart, Lung and Blood Institute |
| NHS EED | NHS Economic Evaluation Database |
| NICE | National Institute for Health and Care Excellence |
| NIHR | National Institute for Health Research |
| NIHSS | National Institutes of Health Stroke Scale |
| NMA | Network meta-analysis |
| NOT | Nocturnal therapy |
| NPT | Normalisation Process Theory |
| NP | Natriuretic peptides including BNP and NT-proBNP |
| NPV | Negative predictive value |
| NR | Not reported |
| NRS | Numerical rating scale |
| NS | Not stated [in study paper] |
| NT-proBNP | N-terminus pro B type natriuretic peptide |
| NYHA | New York Heart Association Classification |
| OECD | Organisation for Economic Co-operation and Development |
| ONS | Office for National Statistics |
| PCI | Percutaneous coronary intervention |
| PCP | Primary care physicians |
| PCS | Physical component summary |
| PDA | Personal digital assistant |
| PICO | Population, intervention, comparison and outcome |
| PND | Paroxysmal nocturnal dyspnoea |
| PPV | Positive predictive value |
| PROBAST | Prediction study Risk of Bias Assessment Tool |
| PSSRU | Personal Social Services Research Unit |
| pt | People with chronic heart failure |
| QALY | Quality-adjusted life years |
| QOL | Quality of life |
| QUADAS-2 | Quality Assessment of Diagnostic Accuracy Studies version 2 |
| RAS | Renin-angiotensin-system |
| RCT | Random control trial |
| RENAISSANCE | Randomized Enbrel North American Strategy to Study Antagonism of Cytokines |
| ROC | Receiver operating characteristics |
| RPE | Rating of Perceived Exertion |
| RR | Relative risk/Risk ratio |
| SA | Sensitivity analysis |
| SBP | Systolic Blood Pressure |
| SD | Standard deviation |
| SE | Standard error |
| SETG | Supervised exercise training group |
| SHFM | Seattle Heart Failure Model |
| SHFM-D | Seattle Heart Failure Model-D |
| SMD | Standard Mean Difference |
| SPECT | Single photon emission computed tomography |
| STS | Structured telephone support |
| STS HH | Structured telephone support via human to human interface |
| SGA | Subgroup analysis |
| TIA | Transient ischaemic attack |
| TM | Telemonitoring |
| TN | True negative |
| TP | True positive |
| TSAT | Transferrin saturations |
| TTO | Time trade off |
| UHFO-IA | Utrecht Heart Failure Organisation–Initial Assessment |
| VAS | Visual analogue scale |
| Acronym or abbreviation | Description |
| ABC | In full |
| ABC | In full |
| ABC | In full |
- Acronyms and abbreviations - Chronic Heart Failure in AdultsAcronyms and abbreviations - Chronic Heart Failure in Adults
Your browsing activity is empty.
Activity recording is turned off.
See more...